Considering fibroid surgery? Answers to questions regarding surgery with power morcellators

The U.S. Food and Drug Administration (FDA) has issued a rare “black box warning” on power morcellation devices for laparoscopic surgery to remove uterine fibroids or to perform a hysterectomy.

The warning cautions women considering undergoing fibroid removal surgery with the devices. The warning tells women that they may wish to choose an alternative type of surgery because surgery with the device could inadvertently spread undetected cancer.

The Wall Street Journal answers five questions about the device warning. You can read more here: 5 QUESTIONS ABOUT THE FDA WARNING ON MORCELLATORS, UTERINE FIBROIDS

According to the FDA, it is estimated that one in 350 women who undergo hysterectomy or fibroid removal surgery has a uterine sarcoma, a kind of cancer. Morcellators are devices that dissect the uterus or fibroids using a spinning blade. However, if the blades come into contact with a malignant cancer, cancer cells can spread in the pelvis and abdomen worsening a person’s likelihood of surviving.

If you or a loved one has had an onset of cancer after power morcellation surgery, you should contact a faulty medical devices attorney about the possibility of filing a lawsuit.

The Farber Law Group, a personal injury law firm in Bellevue, Washington, has represented cases involving faulty medical devices. Call us today for a free and confidential case evaluation.

Contact The Farber Law Group at 1-800-244-9087 or attorney@hgfarber.com to schedule a free and confidential case evaluation. Our Bellevue office is here to assist you.

Related Posts:

Laparoscopic Surgery using a Power Morcellation Device
Can morecellation surgery spread cancer?
Jury decides case of man injured during robotic surgery
Medical malpractice suit: kidney transplant gave man donor’s cancer